Literature DB >> 2537120

A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis.

Y Kaneko1, G Frizzera, S Edamura, N Maseki, M Sakurai, Y Komada, M Sakurai, H Tanaka, M Sasaki, T Suchi.   

Abstract

We report a novel chromosome translocation--t(2;5)(p23;q35) or its variant, t(2;5;13)(p23;q35;q12)--in 3 patients with peripheral T-cell lymphoma. All 3 were female children who had peripheral lymphadenopathy without organomegaly and underwent complete remission with or without chemotherapy. Their tumors were characterized histologically by predominant large cells, at times showing phagocytosis, and immunologically by peripheral T-cell phenotype and expression of Ki-1 antigen and epithelial membrane antigen (EMA). Since the same translocation has been reported in the literature in 4 patients with malignant histiocytosis (MH), and our patients had histologic features suggestive of that disease, it is likely that many tumors previously interpreted as MH are actually phagocytic large T-cell lymphoma carrying this translocation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537120

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  5'-(RACE) identification of rare ALK fusion partner in anaplastic large cell lymphoma.

Authors:  N Scott Reading; Stephen D Jenson; Jeffrey K Smith; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

2.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

Authors:  S Pittaluga; I Wlodarska; K Pulford; E Campo; S W Morris; H Van den Berghe; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 4.  Non-Hodgkin Lymphoma in Children.

Authors:  John T Sandlund
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

5.  Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.

Authors:  S A Pileri; K Pulford; S Mori; D Y Mason; E Sabattini; G Roncador; M Piccioli; C Ceccarelli; P P Piccaluga; D Santini; O Leone; H Stein; B Falini
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 6.  ALK-immunoreactive neoplasms.

Authors:  Parham Minoo; Huan-You Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

Review 7.  Cytogenetics in childhood leukemias and malignant lymphomas.

Authors:  R Abe; Y Maruyama
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

8.  Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.

Authors:  H Ohno; T Furukawa; S Fukuhara; S Q Zong; H Kamesaki; T B Shows; M M Le Beau; T W McKeithan; T Kawakami; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 9.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

10.  Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.

Authors:  J R Lopategui; L H Sun; J K Chan; M J Gaffey; H F Frierson; C Glackin; L M Weiss
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.